Keyphrases
Treg
100%
Vaccine Response
100%
Antitumor Effect
100%
Low-dose Cyclophosphamide
100%
Therapeutic HPV Vaccine
100%
CD8+ T Cells
75%
Daily Dose
75%
CD8+
50%
CD8+ T
50%
T Cells
25%
Monotherapy
25%
Vaccination
25%
Regulatory T Cells
25%
Dosing Schedule
25%
Infiltration
25%
Cyclophosphamide
25%
Immune Cells
25%
Adverse Effects
25%
DNA Vaccine
25%
HPV16 E7
25%
T Cell Response
25%
Cell Function
25%
Myeloid-derived Suppressor Cells
25%
Clinical Response
25%
Tumor-bearing Mice
25%
Human Trials
25%
Observed Trends
25%
High Ratio
25%
Synergistic Antitumor Effect
25%
Cytotoxic CD8+ T Cells
25%
Detox
25%
Specific Immunity
25%
Administration Schedule
25%
In Vitro Tumor Models
25%
Optimal Schedule
25%
Optimal Dose
25%
Gr-1
25%
Immunosuppressive Microenvironment
25%
Anti-tumor Response
25%
CD11b+
25%
Treg Frequency
25%
Immunology and Microbiology
Regulatory T Cell
100%
Low Drug Dose
100%
HPV Vaccine
100%
Cyclophosphamide
100%
Vaccine Efficacy
83%
Cytotoxic T-Cell
83%
CD8
33%
T Cell
33%
Adaptive Immune System
16%
Immunosuppressive Drug
16%
Mouse
16%
Cell Function
16%
Immunocompetent Cell
16%
Myeloid-Derived Suppressor Cell
16%
DNA Vaccine
16%
Human Papillomavirus Type 16
16%
Phosphoryl Lipid A
16%
Optimal Drug Dose
16%
Immunotherapy
16%
Vaccination Policy
16%